PT-141 (Bremelanotide, brand name Vyleesi) is a synthetic melanocortin peptide derived from Melanotan II, specifically designed to target the MC4 receptor pathway responsible for sexual arousal. Unlike PDE5 inhibitors (Viagra, Cialis) that work on blood flow, PT-141 acts centrally in the brain on the arousal pathway itself.
PT-141 was developed after researchers studying Melanotan II noticed significant pro-sexual effects. By removing the UV-stimulated tanning component and optimizing for MC4R selectivity, they created a targeted sexual function drug that was eventually FDA-approved in 2019 as Vyleesi for premenopausal women with hypoactive sexual desire disorder (HSDD).
PT-141 works for both men and women because it targets the central desire pathway rather than peripheral blood flow. For men, it can be effective where PDE5 inhibitors fail (particularly in cases of psychogenic erectile dysfunction or low libido). For women, it addresses desire rather than arousal mechanics.
Looking for the best vendor deals?
Compare prices across 10+ peptide and anabolic vendors. Find the best quality at the lowest price.
Compare Vendors